Baryton Pharma Private Limited, a active private limited company, was established on 17 September 2010 in Kozhikode, Kerala, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24232KL2010PTC026716. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Its leadership includes Ranjish Rayaroth (Director), Praveen Viswakumar (Director), Chelakkara Vaidyanathan Sriram (Managing Director). Past directors included Peeja Rajan, Chelakkara Vaidyanathan Sriram, Shiju Chembra. It holds ₹2.62 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Door No .18/1001- D, Puthiyapalam Road,Tali (P.O), Kozhikode, Kerala, 673002.
U24232KL2010PTC026716
026716
17 September 2010
₹0.50 M
₹0.50 M
Roc Ernakulam
Unlisted
Active
Explore comprehensive insights into Baryton Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ranjish Rayaroth | Director | 06 Jan 2011 | Current |
| Praveen Viswakumar | Director | 06 Jan 2011 | Current |
| Chelakkara Vaidyanathan Sriram | Managing Director | 17 Sep 2010 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 06 Jan 2011 | Past |
| Pramod Abcsdd | Director | 01 Jan 2011 | Past |
| Pramod Abcsdd | Director | 23 Apr 2021 | Past |
| Pramod Abcsdd | Director | 06 Jan 2011 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Baryton Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 39.12% increase. The company also saw a substantial improvement in profitability, with a 92.58% increase in profit. The company's net worth Soared by an impressive increase of 23.03%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Baryton Pharma had a public holding of 41.14%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹26,225,665.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Aug 2025 | Hdfc Bank Limited | ₹4.25 M | Open |
| 30 Jul 2025 | Hdfc Bank Limited | ₹4.10 M | Open |
| 06 Jan 2025 | Others | ₹1.20 Cr | Open |
| 02 Mar 2024 | Hdfc Bank Limited | ₹5.28 M | Open |
| 04 Feb 2022 | Hdfc Bank Limited | ₹0.60 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Baryton Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Baryton Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Baryton Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge with Hdfc Bank Limited amounted to Rs. 4.25 M with Charge ID 101170297 was registered on 04 Aug 2025. was recorded as a recent event.
The activity A charge with Hdfc Bank Limited amounted to Rs. 4.10 M with Charge ID 101170271 was registered on 30 Jul 2025. was completed.
The activity A charge with Others amounted to Rs. 12.00 M with Charge ID 101032760 was registered on 06 Jan 2025. was completed.
Progress on Baryton Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Baryton Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ernakulam. was recorded as a recent event.
The activity A charge with Hdfc Bank Limited amounted to Rs. 5.28 M with Charge ID 100912072 was registered on 02 Mar 2024. was completed.
The CIN of Baryton Pharma Private Limited is U24232KL2010PTC026716.
Baryton Pharma Private Limited is headquartered at Door No .18/1001- D, Puthiyapalam Road,Tali (P.O), Kozhikode, Kerala, 673002.
Baryton Pharma Private Limited was incorporated on 17 September 2010.
The current directors of Baryton Pharma Private Limited are
The primary industry of Baryton Pharma Private Limited is Trade.
Baryton Pharma Private Limited is unlisted.
The authorized capital of Baryton Pharma Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
The compliance status of Baryton Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX